Medications

No significant association found for ADHD meds, CVD risk

There seems to be no statistically significant association between attention-deficit/hyperactivity disorder (ADHD) medications and cardiovascular disease (CVD) risk, according to a systematic review and meta-analysis published ...

Attention deficit disorders

Researchers identify brain markers of ADHD in children

Researchers analyzing the data from MRI exams on nearly 8,000 children have identified biomarkers of attention-deficit/hyperactivity disorder (ADHD) and a possible role for neuroimaging machine learning to help with the diagnosis, ...

Genetics

Researchers unlock pattern of gene activity for ADHD

Researchers at the National Institutes of Health have successfully identified differences in gene activity in the brains of people with attention deficit hyperactivity disorder (ADHD). The study, led by scientists at the ...

Psychology & Psychiatry

Teens with ADHD do not report worse quality of life

A diagnosis of attention-deficit/hyperactivity disorder (ADHD) does not appear to lower overall self-reported quality of life (QOL) among adolescents (aged 14 to 15 years), according to a study published online Oct. 13 in ...

Medications

FDA says ADHD med Adderall is in short supply

People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.

page 14 from 40